Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Cassava Sciences Inc (FLNA) – Cassava Sciences Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

FLNA stock trades at $1.62, down 1.22% on the day, with a bearish technical signal from moving averages. The company shows significant financial challenges, with negative ROE of -82.66% and ROA of -65.95%, and consistent negative operating cash flow. However, it has beaten earnings expectations in recent quarters, and analyst sentiment remains positive with 8 buy ratings and no sell ratings among 12 analysts covering the stock.
The outlook is mixed: strong analyst support contrasts with fundamental weakness. Investment opportunity exists if the company can translate recent earnings beats into sustainable cash flow improvement. Primary risks include persistent cash burn, negative profitability metrics, and the need for continued financing to fund operations.
Read full analysis

Key Stats

  • Market Cap
    $79.22M
  • Sector
    Health
  • 3M Drawdown
    -33.88%
  • Enterprise Value
    -$16.28M
  • Dividend Yield
    -
  • Trading Activity
    0% Buy | 100% Sell
  • Typical Hold Time
    33 days
$1.57
52W Low: $1.27
11 Apr 2025
52W High: $4.64
15 Oct 2025

Cassava Sciences Inc (FLNA) is currently valued at a market capitalization of $79.22M, with an enterprise value of -$16.28M. Over the past 52 weeks, Cassava Sciences Inc has traded between a low of $1.27 and a high of $4.64, highlighting its annual price range. Over the past three months, Cassava Sciences Inc has recorded a drawdown of -33.88%, reflecting recent price volatility. On average, investors hold Cassava Sciences Inc for approximately 33 days, indicating typical investor behavior on the platform.

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease


Technical Indicators
|
|
|
Overall Summary
Bearish (19)Neutral (0)Bullish (8)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $79.22M
  • Sector
    Health
  • 3M Drawdown
    -33.88%
  • Enterprise Value
    -$16.28M
  • Dividend Yield
    -
  • Trading Activity
    0% Buy | 100% Sell
  • Typical Hold Time
    33 days
$1.57
52W Low: $1.27
11 Apr 2025
52W High: $4.64
15 Oct 2025

Cassava Sciences Inc (FLNA) is currently valued at a market capitalization of $79.22M, with an enterprise value of -$16.28M. Over the past 52 weeks, Cassava Sciences Inc has traded between a low of $1.27 and a high of $4.64, highlighting its annual price range. Over the past three months, Cassava Sciences Inc has recorded a drawdown of -33.88%, reflecting recent price volatility. On average, investors hold Cassava Sciences Inc for approximately 33 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!